Zoetis (TICKER: ZTS) Benchmark And Performance Data

there are 4 of samples in the benchmark for Zoetis in year 2022 in 2022. Zoetis in its benchmark peer group, had rank 4 for sales growth in 2022. Zoetis in its benchmark peer group, had rank 4 for cash to cash cycle time in 2022. Zoetis in its benchmark peer group, had rank 4 days for days of inventory in 2022. Zoetis in its benchmark peer group, had rank 2 for gross revenue in 2022. Zoetis in its benchmark peer group, had rank 1 for cost of goods sold as a percent of revenue in 2022. Zoetis in its benchmark peer group, had rank 1 days for days sales outstanding in 2022. Zoetis headquarters region is East. Zoetis has ticker symbol ZTS. Zoetis has the following profile: Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products.. Zoetis has primary indstury Drug Manufacturers - Specialty & Generic. Zoetis had a $$818,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Zoetis had Elanco Animal Health, and Viatris, and Zoetis, and Catalent benchmark peer companies for its SIC code in 2022. Zoetis had 84 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Zoetis had 13,800 number of employees in 2022. Zoetis had 108 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Zoetis had 0.12% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Zoetis had 0.00% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Zoetis had 0.00% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Zoetis had 0.00% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Zoetis had 0 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Zoetis can reduce overall cost by $$306,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Zoetis can reduce inventory with practices including SKU Reduction in 2022. Zoetis can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Zoetis can reduce inventory with practices including Forecast Accuracy in 2022. Zoetis can reduce inventory with practices including Demand Shaping in 2022. Zoetis can reduce days sales outstanding with practices including in 2022. Zoetis can increase sales revenue by $$818,000,000 improving sales performance to next benchmark tier in 2022. Zoetis can increase revenue growth by $$10,000,000 by improving growth performance to next benchmark tier in 2022. Zoetis can increase overall revenue by $$828,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Zoetis can increase days payables outstanding with practices including Strategic Sourcing in 2022. Zoetis can increase days payables outstanding by $217,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Zoetis can improve total financial performance by $$3,742,000,000 by improving revenue, costs, and working capital in 2022. Zoetis can decrease overall working capital by $$2,608,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Zoetis can decrease inventory days by $2,391,000,000 days by reducing inventory days to next benchmark tier in 2022. Zoetis can decrease days sales outstanding by $0 days by reducing days sales outstanding to next benchmark tier in 2022. Zoetis can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Zoetis can accelerate revenue growth practices including Pricing Optimization in 2022. Zoetis can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. The total inventory for Zoetis was $1,923,000,000.00 in 2021. The total inventory for Zoetis was $1,628,000,000.00 in 2020. The total inventory for Zoetis was $1,502,000,000.00 in 2016. The total inventory for Zoetis was $1,467,000,000.00 in 2015. The total inventory for Zoetis was $1,427,000,000.00 in 2017. The total inventory for Zoetis was $1,410,000,000.00 in 2019. The total inventory for Zoetis was $1,391,000,000.00 in 2018. The total inventory for Zoetis was $1,345,000,000.00 in 2012. The total inventory for Zoetis was $1,293,000,000.00 in 2013. The total inventory for Zoetis was $1,289,000,000.00 in 2014. The sales, general, and administrative (SGA) for Zoetis was $2,001,000,000.00 in 2021. The sales, general, and administrative (SGA) for Zoetis was $1,726,000,000.00 in 2020. The sales, general, and administrative (SGA) for Zoetis was $1,643,000,000.00 in 2014. The sales, general, and administrative (SGA) for Zoetis was $1,638,000,000.00 in 2019. The sales, general, and administrative (SGA) for Zoetis was $1,613,000,000.00 in 2013. The sales, general, and administrative (SGA) for Zoetis was $1,532,000,000.00 in 2015. The sales, general, and administrative (SGA) for Zoetis was $1,484,000,000.00 in 2018. The sales, general, and administrative (SGA) for Zoetis was $1,470,000,000.00 in 2012. The sales, general, and administrative (SGA) for Zoetis was $1,364,000,000.00 in 2016. The sales, general, and administrative (SGA) for Zoetis was $1,334,000,000.00 in 2017. The sales, general, and administrative (SGA) for Zoetis was $$2,009,000,000 in 2022. The revenue volatility for Zoetis was 12.55% in 2022. The market capitalization for Zoetis was $91,900,839,425.00 in 2013. The market capitalization for Zoetis was $88,865,268,157.00 in 2015. The market capitalization for Zoetis was $88,373,930,278.00 in 2012. The market capitalization for Zoetis was $80,549,965,576.00 in 2016. The market capitalization for Zoetis was $80,085,935,131.00 in 2021. The market capitalization for Zoetis was $79,345,869,780.00 in 2020. The market capitalization for Zoetis was $76,977,724,888.00 in 2019. The market capitalization for Zoetis was $69,168,698,267.00 in 2017. The market capitalization for Zoetis was $68,302,850,867.00 in 2018. The market capitalization for Zoetis was $115,322,255,182.00 in 2014. The market capitalization for Zoetis was $$85,427,000,000 in 2022. The gross revenue for Zoetis was $7,776,000,000.00 in 2021. The gross revenue for Zoetis was $6,675,000,000.00 in 2020. The gross revenue for Zoetis was $6,260,000,000.00 in 2019. The gross revenue for Zoetis was $5,825,000,000.00 in 2018. The gross revenue for Zoetis was $5,307,000,000.00 in 2017. The gross revenue for Zoetis was $4,888,000,000.00 in 2016. The gross revenue for Zoetis was $4,785,000,000.00 in 2014. The gross revenue for Zoetis was $4,765,000,000.00 in 2015. The gross revenue for Zoetis was $4,561,000,000.00 in 2013. The gross revenue for Zoetis was $4,336,000,000.00 in 2012. The gross revenue for Zoetis was $$8,080,000,000 in 2022. The gross margin for Zoetis was $36.24% in 2022. The days sales outstanding for Zoetis was 53 days in 2022. The days payable outstanding for Zoetis was 63 days in 2022. The days of inventory for Zoetis was $317 in 2022. The cost of goods sold (COGS) for Zoetis was 30.37% in 2022. The cost of goods sold (COGS) for Zoetis was $2,303,000,000.00 in 2021. The cost of goods sold (COGS) for Zoetis was $2,057,000,000.00 in 2020. The cost of goods sold (COGS) for Zoetis was $1,992,000,000.00 in 2019. The cost of goods sold (COGS) for Zoetis was $1,911,000,000.00 in 2018. The cost of goods sold (COGS) for Zoetis was $1,775,000,000.00 in 2017. The cost of goods sold (COGS) for Zoetis was $1,738,000,000.00 in 2015. The cost of goods sold (COGS) for Zoetis was $1,717,000,000.00 in 2014. The cost of goods sold (COGS) for Zoetis was $1,669,000,000.00 in 2013. The cost of goods sold (COGS) for Zoetis was $1,666,000,000.00 in 2016. The cost of goods sold (COGS) for Zoetis was $1,563,000,000.00 in 2012. The cost of goods sold (COGS) for Zoetis was $$2,454,000,000 in 2022. The cash to cash cycle time for Zoetis was 307 in 2022. The annual percentage growth rate of Zoetis was -0.04% in 2022. 73 days was the measured parity or middle performance level for days sales outstanding in Zoetis's peer group in 2022. 66 days was the measured advantage or top third performance level for days sales outstanding in Zoetis's peer group in 2022. 57 days was the measured superior or top ten performance level for days sales outstanding in Zoetis's peer group in 2022. 51.71% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Zoetis's peer group in 2022. 42.07% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Zoetis's peer group in 2022. 34.27% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Zoetis's peer group in 2022. 28.42% was the measured superior or top ten performance level for gross margin in Zoetis's peer group in 2022. 223 days was the measured parity or middle performance level for cash to cash cycle time in Zoetis's peer group in 2022. 209 days was the measured parity or middle performance level for days of inventory in Zoetis's peer group in 2022. 19.60% was the measured parity or middle performance level for sales volatility in Zoetis's peer group in 2022. 18.77% was the measured advantage or top third performance level for sales volatility in Zoetis's peer group in 2022. 173 days was the measured advantage or top third performance level for cash to cash cycle time in Zoetis's peer group in 2022. 142 days was the measured superior or top ten performance level for cash to cash cycle time in Zoetis's peer group in 2022. 14.62% was the measured superior or top ten performance level for sales volatility in Zoetis's peer group in 2022. 135 days was the measured advantage or top third performance level for days of inventory in Zoetis's peer group in 2022. 102 days was the measured superior or top ten performance level for days of inventory in Zoetis's peer group in 2022. 0.11% was the measured superior or top ten performance level for sales growth in Zoetis's peer group in 2022. 0.09% was the measured advantage or top third performance level for sales growth in Zoetis's peer group in 2022. 0.08% was the measured parity or middle performance level for sales growth in Zoetis's peer group in 2022. $9.44% was the measured parity or middle performance level for gross margin in Zoetis's peer group in 2022. $12.79% was the measured advantage or top third performance level for gross margin in Zoetis's peer group in 2022. $$8,898,000,000 was the measured advantage or top third performance level for gross revenue in Zoetis's peer group. $$6,245,000,000 was the measured parity or middle performance level for gross revenue in Zoetis's peer group in 2022. $$13,808,000,000 was the measured superior or top ten performance level for gross revenue in Zoetis's peer group in 2022.